December 27, 2016—(BRONX, NY)—Investigators at Albert Einstein College of Medicine were awarded more than $160 million from the National Institutes of Health in federal fiscal year 2016. The grants provide critical support for major research projects in aging, intellectual and developmental disabilities, diabetes, cancer and infectious diseases. Other key areas for which Einstein received federal support include developmental brain research, neuroscience, advanced cellular imaging, cardiac disease and initiatives to reduce health disparities.
“During this period of transition for Einstein, this level of funding convincingly demonstrates the excellence of our faculty and the research they conduct.”– Dean Allen M. Spiegel, M.D.
“During this period of transition for Einstein, this level of funding convincingly demonstrates the excellence of our faculty and the importance of the research they conduct,” says Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean at Einstein and executive vice president and chief academic officer at Montefiore Medicine. “This strong showing in our first year as part of Montefiore bodes well for our integrated research enterprise, as opportunities and collaborations develop and deepen.”
In addition to grants for investigator-initated research projects and training for students, faculty and postdoctoral fellows, Einstein received major new and renewal awards for Einstein centers, including:
Other major program and collaboration grants were:
Read about more Einstein grants, as well as published research, in Research Round-up.